TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 227 filers reported holding TANDEM DIABETES CARE INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $554,414 | -4.4% | 26,693 | +13.0% | 0.01% | 0.0% |
| Q2 2023 | $579,831 | -39.6% | 23,628 | 0.0% | 0.01% | -42.1% |
| Q1 2023 | $959,533 | -9.7% | 23,628 | 0.0% | 0.02% | -17.4% |
| Q4 2022 | $1,062,079 | +14.2% | 23,628 | +21.5% | 0.02% | +9.5% |
| Q3 2022 | $930,000 | -32.6% | 19,444 | -16.5% | 0.02% | +10.5% |
| Q2 2022 | $1,379,000 | -49.7% | 23,298 | -1.2% | 0.02% | -38.7% |
| Q1 2022 | $2,743,000 | -61.9% | 23,588 | -50.7% | 0.03% | -53.7% |
| Q4 2021 | $7,204,000 | +35.4% | 47,861 | +7.4% | 0.07% | +31.4% |
| Q3 2021 | $5,321,000 | +13.5% | 44,568 | -7.4% | 0.05% | +21.4% |
| Q2 2021 | $4,690,000 | +7.0% | 48,147 | -3.1% | 0.04% | +2.4% |
| Q1 2021 | $4,385,000 | -9.5% | 49,688 | -1.9% | 0.04% | -8.9% |
| Q4 2020 | $4,844,000 | +112.3% | 50,630 | +151.8% | 0.04% | +80.0% |
| Q3 2020 | $2,282,000 | – | 20,105 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 1,000,000 | $59,610,000 | 47.04% |
| Prospect Capital Advisors, LLC | 127,900 | $7,624,000 | 4.68% |
| Asymmetry Capital Management, L.P. | 43,559 | $2,597,000 | 4.66% |
| Copernicus Capital Management, LLC | 50,000 | $2,981,000 | 3.91% |
| SECTORAL ASSET MANAGEMENT INC | 341,714 | $20,370,000 | 3.04% |
| FRIESS ASSOCIATES LLC | 627,225 | $37,389,000 | 2.60% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,361,345 | $81,150,000 | 2.59% |
| Parkman Healthcare Partners LLC | 134,959 | $8,045,000 | 2.32% |
| OBERWEIS ASSET MANAGEMENT INC/ | 109,940 | $6,554,000 | 2.18% |
| First Light Asset Management, LLC | 268,574 | $16,010,000 | 2.05% |